Aulma Parker

Title: Aulma Parker: Innovator in Diabetes Treatment

Introduction

Aulma Parker is a notable inventor based in San Antonio, TX, who has made significant contributions to the field of diabetes treatment. With a total of six patents to his name, Parker has focused on developing methods and formulations that aim to reduce the toxicity associated with diabetes therapies. His work is crucial in improving the quality of life for diabetic patients.

Latest Patents

Among his latest patents, Parker has developed innovative formulations and methods for reducing unwanted toxicity and complications associated with treatments for diabetes mellitus. These formulations include co-formulations of an anti-diabetic agent and a toxicity-reducing agent, which are designed to be administered in effective amounts to safely treat diabetic patients. Additionally, he has created a method for treating diabetic ophthalmopathy, which involves administering an effective amount of a thiol or reducible disulfide compound to patients in need of treatment.

Career Highlights

Throughout his career, Aulma Parker has worked with various organizations, including Bionumerik Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to develop groundbreaking solutions for diabetes management.

Collaborations

Parker has collaborated with notable professionals in his field, including Frederick H Hausheer and Seetharamulu Peddaiaghari. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Aulma Parker's contributions to diabetes treatment through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches continue to pave the way for safer and more effective diabetes therapies.